Bleichroeder LP 13D/13G Filings for Cue Biopharma, Inc. (CUE)

Bleichroeder LP 13D and 13G filings for Cue Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-03-21
7:14 pm
Unchanged		 2025-03-19 13G Cue Biopharma, Inc.
CUE		 Bleichroeder LP 6,127,662
9.990%		 0
(Unchanged)		 Filing
2024-10-07
5:07 pm
Purchase		 2024-09-30 13G Cue Biopharma, Inc.
CUE		 Bleichroeder LP 6,127,662
9.990%		 3,372,634increase
(+122.42%)		 Filing
2024-03-11
6:40 pm
Purchase		 2024-02-27 13G Cue Biopharma, Inc.
CUE		 Bleichroeder LP 2,755,028
6.110%		 2,755,028increase
(New Position)		 Filing